Provided by Tiger Trade Technology Pte. Ltd.

10x Genomics, Inc.

18.88
-0.3100-1.62%
Post-market: 18.880.00000.00%19:38 EST
Volume:2.30M
Turnover:44.13M
Market Cap:2.41B
PE:-54.09
High:19.89
Open:19.15
Low:18.77
Close:19.19
52wk High:23.56
52wk Low:6.78
Shares:127.69M
Float Shares:115.00M
Volume Ratio:0.71
T/O Rate:2.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3490
EPS(LYR):-0.3490
ROE:-5.78%
ROA:-6.40%
PB:3.03
PE(LYR):-54.09

Loading ...

Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and 10x Genomics (TXG)

TIPRANKS
·
4 hours ago

10x Genomics Is Maintained at Neutral by UBS

Dow Jones
·
Yesterday

UBS Adjusts Price Target on 10x Genomics to $20 From $14, Maintains Neutral Rating

MT Newswires Live
·
Feb 20

UBS Reaffirms Their Hold Rating on 10x Genomics (TXG)

TIPRANKS
·
Feb 20

10x Genomics to Join TD Cowen Health Care Conference Fireside Chat

Reuters
·
Feb 20

10x Genomics (TXG) Is Down 5.4% After Shelf Offer Filing And Cautious 2026 Outlook What's Changed

Simply Wall St.
·
Feb 18

Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum

Simply Wall St.
·
Feb 15

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX) and 10x Genomics (TXG)

TIPRANKS
·
Feb 15

Risk Factors Weigh on 10X Genomics: Uncertain Guidance, Stock Volatility, and Capital-Raising Challenges

TIPRANKS
·
Feb 14

Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS), Humana (HUM) and 10x Genomics (TXG)

TIPRANKS
·
Feb 13

Stock Track | 10x Genomics Soars 16.79% Intraday on Multiple Analyst Target Price Raises

Stock Track
·
Feb 13

Stock Track | 10x Genomics Soars 9.94% in Pre-Market on Multiple Analyst Target Price Raises

Stock Track
·
Feb 13

U.S. RESEARCH ROUNDUP-Applied Materials, Humana, Waste Connections

Reuters
·
Feb 13

Stock Track | 10x Genomics Soars 6.34% in After-Hours Trading on Strong Q4 Earnings Beat and Positive 2026 Outlook

Stock Track
·
Feb 13

Stock Track | 10x Genomics Soars 6.05% After-Hours on Strong Q4 Earnings Beat and Positive 2026 Outlook

Stock Track
·
Feb 13

10x Genomics Q4 Loss Narrows, Revenue Rises; 2026 Guidance Set

MT Newswires Live
·
Feb 13

Stock Track | 10x Genomics Plunges 10.85% After-Hours on Weak 2026 Revenue Outlook

Stock Track
·
Feb 13

10x Genomics sees 2026 revenue $600M-$625M, consensus $611.77M

TIPRANKS
·
Feb 13

10x Genomics Q4 revenue totals USD 166.03 million, up 1 percent

Reuters
·
Feb 13

BRIEF-10X Genomics Q4 Gross Margin 68%

Reuters
·
Feb 13